It was demonstrated that miR-185 could suppress Wnt/β-catenin signalling and modulate the transcription and translation levels of downstream molecules of this pathway, including MYC and CCND1, in human colorectal cancer, thus exerting tumour suppressor effects [22]. This evidence concerns the gene CCND1 and neoplasm.